Semi-quantitative analysis of Streptococcus pneumoniae urinary antigen: Kinetics of antigen titers and severity of diseases
Authors:
- Kazuhiro TatedaKTKazuhiro Tateda
- Emiko KusanoEKEmiko Kusano
- Tetsuya MatsumotoTMTetsuya Matsumoto
- Kazuhiro KimuraKKKazuhiro Kimura
- Koh UchidaKUKoh Uchida
- Koichiro NakataKNKoichiro Nakata
- Keizo YamaguchiKYKeizo Yamaguchi
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 38 (3) , 166-171
Abstract
Detection of urinary antigen by a rapid immunochromatographic membrane test (Binax NOW) was widely accepted as a powerful tool for diagnosis of Streptococcus pneumoniae pneumonia. This is a qualitative kit, so the value of quantitative analysis of urinary antigen, especially correlation of antigen titers and severity of diseases, remained to be determined. We examined semi-quantitative antigen titer in urines collected from urinary antigen-proven S. pneumoniae pneumonia on admission, and analyzed the kinetics of antigen titer and its relation to severity of diseases. After serial 2-fold dilution of urine, the highest dilution for positive results was determined, and this was designated as maximum dilution factor (MDF). MDFs varied from 1 to 4096 in 29 patients examined (mean MDF, 317.8). Importantly, severe cases of S. pneumoniae pneumonia were higher values of MDFs (mean MDF: 760.5) than those of non-severe cases (mean MDF: 5.4). The patients with high MDFs (> or = 64) demonstrated higher values of LDH, CRP and lower values of WBC and PaO2 compared to those of low MDFs group (< or = 32). There was no clear correlation between CRP values and antigen titers, and conversely the majority of severe cases showed relatively weak CRP responses, despite high levels of bacterial antigen. Kinetic analysis of urinary and serum antigen titers in 4 cases of S. pneumoniae pneumonia exhibited consistently higher values of antigen titers in urine than those in serum. The half lives of urinary and serum antigen titers were calculated to be 1.0-3.4 and 1.1-2.3 weeks, respectively. These data suggest that quantitative analysis of urinary antigen may be a useful indicator for severity of disease and course of S. pneumoniae pneumonia. Our results demonstrate an application for S. pneumoniae antigen titer determination in urine and serum, which may be crucial not only for diagnostic measures, but also may provide a better understanding of the pathogenesis of S. pneumoniae infection.Keywords
This publication has 25 references indexed in Scilit:
- Contribution of a Urinary Antigen Assay (Binax NOW) to the Early Diagnosis of Pneumococcal PneumoniaClinical Infectious Diseases, 2004
- Rapid Diagnosis of Bacteremic Pneumococcal Infections in Adults by Using the Binax NOW Streptococcus pneumoniae Urinary Antigen Test: a Prospective, Controlled Clinical EvaluationJournal of Clinical Microbiology, 2003
- Classical and Latent Class Analysis Evaluation of Sputum Polymerase Chain Reaction and Urine Antigen Testing for Diagnosis of Pneumococcal Pneumonia in AdultsThe Journal of Infectious Diseases, 2003
- Evaluation of the Immunochromatographic Binax NOW Assay for Detection ofStreptococcus pneumoniaeUrinary Antigen in a Prospective Study of Community‐Acquired Pneumonia in SpainClinical Infectious Diseases, 2003
- Evaluation of a Rapid Immunochromatographic Test for Detection of Streptococcus pneumoniae Antigen in Urine Samples from Adults with Community-Acquired PneumoniaJournal of Clinical Microbiology, 2001
- Guidelines for the Management of Adults with Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatographic Assay in Urine SamplesChest, 2001
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Severe Community-acquired Pneumonia: Assessment of Severity CriteriaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Prognosis and Outcomes of Patients With Community-Acquired PneumoniaJAMA, 1996